| For: | Chen YC, Li DB, Wang DL, Peng H. Comprehensive analysis of distal-less homeobox family gene expression in colon cancer. World J Gastrointest Oncol 2023; 15(6): 1019-1035 [PMID: 37389108 DOI: 10.4251/wjgo.v15.i6.1019] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5204/full/v15/i6/1019.htm |
| Number | Citing Articles |
| 1 |
Jian Yao, Qiang Zhang, Chunhe Zhong, Haiyang Zhang, Xinchi Lei, Dongbing Li. Decoding PRTFDC1's Role in Lung Adenocarcinoma: From Gene Expression to Clinical Implications. Current Medicinal Chemistry 2026; 33(25) doi: 10.2174/0109298673367449250728104846
|
| 2 |
Jieli Zhang, Yanqiu Zhou, Xiaoli Li, Shufang Wang, Peng Zhang, Dongbing Li, Yunzhi Zhou. Expression Profile and Prognostic Values of IRX Family Members in Lung Adenocarcinoma. Current Medicinal Chemistry 2025; 32(35) doi: 10.2174/0109298673320965240829065919
|
| 3 |
Ming Yang, ZhaoYue Wang, Riga Su, Dongbing Li, Jun Zhou. Identification of Key Genes and Pathways in Lenvatinib-resistant Hepatocellular Carcinoma using Bioinformatic Analysis and Experimental Validation. Current Medicinal Chemistry 2025; 32(37) doi: 10.2174/0109298673329991241111111941
|
| 4 |
Guizhen Lyu. Bioinformatic Analysis and Experimental Validation of HMGA2-AS1 as a Prognostic Biomarker Associated with Immune Infiltration in Gastric Cancer. Recent Patents on Anti-Cancer Drug Discovery 2025; 20(3) doi: 10.2174/0115748928284459240318070914
|
| 5 |
Hsu-Wen Chao, Yi-Mei Joy Lin, Chen-Shiou Wu. Biomarker-Based Precision Prediction of Immunotherapy Response in Hepatocellular Carcinoma. Diagnostics 2025; 16(1) doi: 10.3390/diagnostics16010085
|
| 6 |
Hanping He, Feng Yuan, Ying Li, Guoliang Pi, Hongwei Shi, Yanping Li, Guang Han. Comprehensive Analysis and Experimental Validation of FOXD2 as a Novel Potential Prognostic Biomarker Associated with Immune Infiltration in Head and Neck Squamous Cell Carcinoma. Current Computer-Aided Drug Design 2025; 21(6) doi: 10.2174/0115734099302492240405065505
|
| 7 |
Amin Ullah, Yongxiu Chen, Rajeev K. Singla, Dan Cao, Bairong Shen. Pro-inflammatory cytokines and CXC chemokines as game-changer in age-associated prostate cancer and ovarian cancer: Insights from preclinical and clinical studies' outcomes. Pharmacological Research 2024; 204 doi: 10.1016/j.phrs.2024.107213
|
| 8 |
Hongping Zhang, Xilin Zhu, Xiaoxue Zi, Xu Liang, Tongdong Su, Kena Yu, Hailing Zhang. DLX5 regulates nasal Epithelial Mesenchymal Transition and inflammation in EosCRSwNPs via the COL1A1-mediated Wnt/β-catenin Signaling. International Immunopharmacology 2026; 172 doi: 10.1016/j.intimp.2026.116187
|
| 9 |
Limin Zhu, Xiaowei Huang, Fan Zhang, Jinzu Yang, Zhenye Xu. Mendelian Randomization Analysis of Mitochondria‐Related Genes and Screening of Prognostic Genes in Colorectal Cancer. Cancer Medicine 2025; 14(13) doi: 10.1002/cam4.71012
|
| 10 |
Uğur Topaloğlu, Mehmet Erdem Akbalik. The Immunohistochemical Demonstration of the Dlx‐5, HLX and TLX1 Proteins in the Bovine Gastric Compartments Throughout Prenatal Development. Anatomia, Histologia, Embryologia 2025; 54(4) doi: 10.1111/ahe.70053
|
| 11 |
Hongjie Cai, Song Chen, Zhiqiang Wu, Fan Wang, Shuangyan Tang, Dongbing Li, Dongliang Wang, Wenbo Guo. Comprehensive analysis of ZNF692 as a potential biomarker associated with immune infiltration in a pan cancer analysis and validation in hepatocellular carcinoma. Aging 2023; 15(22) doi: 10.18632/aging.205218
|
| 12 |
Shigui Xing, Dongbing Li, Qi Zhao. RPL22L1 is a novel biomarker for prognosis and immune infiltration in lung adenocarcinoma, promoting the growth and metastasis of LUAD cells by inhibiting the MDM2/P53 signaling pathway. Aging 2024; 16(17) doi: 10.18632/aging.206096
|
| 13 |
Yanli Wang, Wei Li, Su Wei, Lixi Zhang, Dongbing Li, Xu Qi. DDX59-AS1: A Novel Prognostic Biomarker and Immunotherapy Predictor in Lung Adenocarcinoma. Current Medicinal Chemistry 2026; 33(8) doi: 10.2174/0109298673359149250212073143
|
| 14 |
Guijun Zou, Yiwei Jiang, Rui Ma, Songyan Li, Chaojun Zhang. Apigenin 7-glucoside reprograms tumor metabolism and enhances immunotherapy efficacy in colorectal cancer via DLX5. Clinical and Translational Oncology 2026; 28(8) doi: 10.1007/s12094-026-04286-9
|
| 15 |
Yanqing Sun, Chun Gao, Dong Jia, Qiang Ma, Wei Wang, Saeed Mohammadi. A Novel Mitochondria‐Associated Programmed Cell Death–Related Prognostic Model and Validation of Oncogene INHBB in Colorectal Cancer. International Journal of Genomics 2025; 2025(1) doi: 10.1155/ijog/8691810
|
| 16 |
Yan Wang, Shiying Feng, Zifan Feng, Jie Yin, Yuzhi Zhang, Hezhao Zhang, Manyu Li, Jia Wu, Rui Zhang. Identification Of ANGPT2, FLT3, IGF1, and SPP1 associated with glycolysis and PI3K/Akt signaling pathway in hepatocellular carcinoma. Gene 2025; 966 doi: 10.1016/j.gene.2025.149644
|
| 17 |
Hui-Yan Wang, Yan Diao, Pei-Zhu Tan, Huan Liang. Four centrosome-related genes to predict the prognosis and drug sensitivity of patients with colon cancer. World Journal of Gastrointestinal Oncology 2024; 16(5): 1908-1924 doi: 10.4251/wjgo.v16.i5.1908
|